IODOTOPE Drug Patent Profile
✉ Email this page to a colleague
When do Iodotope patents expire, and when can generic versions of Iodotope launch?
Iodotope is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in IODOTOPE is sodium iodide i-131. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-131 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IODOTOPE?
- What are the global sales for IODOTOPE?
- What is Average Wholesale Price for IODOTOPE?
Summary for IODOTOPE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Clinical Trials: | 4 |
| Patent Applications: | 39 |
| DailyMed Link: | IODOTOPE at DailyMed |
Recent Clinical Trials for IODOTOPE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Academic and Community Cancer Research United | Phase 2 |
| National Cancer Institute (NCI) | Phase 1 |
| University of Washington | Phase 1 |
US Patents and Regulatory Information for IODOTOPE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | IODOTOPE | sodium iodide i-131 | CAPSULE;ORAL | 010929-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bracco | IODOTOPE | sodium iodide i-131 | CAPSULE;ORAL | 010929-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bracco | IODOTOPE | sodium iodide i-131 | SOLUTION;ORAL | 010929-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
